Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS

PHASE3CompletedINTERVENTIONAL
Enrollment

625

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Advanced Gastric Cancer
Interventions
DRUG

S-1 and cisplatin

"S-1: 80 mg/m2/day po on Days 1-14~cisplatin: 60 mg/m2 iv on Day 1"

DRUG

S-1 and cisplatin

"S-1: 80 mg/day with BSA less than 1.25 m2, 100 mg/day with BSA more than 1.25 m2 and less than 1.5 m2, 120 mg/day with BSA more than 1.5 m2 on Days 1-21 and~cisplatin: 60 mg/m2 iv on Day 1 or 8"

Trial Locations (1)

138-736

Department of Oncology, Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Samsung Medical Center

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

Seoul Veterans Hospital

OTHER

collaborator

National Cancer Center, Korea

OTHER_GOV

collaborator

Ulsan University Hospital

OTHER

collaborator

Inje University

OTHER

collaborator

Chonbuk National University Hospital

OTHER

collaborator

Gachon University Gil Medical Center

OTHER

collaborator

Korea Cancer Center Hospital

OTHER

collaborator

Yeungnam University College of Medicine

OTHER

collaborator

Hallym University Medical Center

OTHER

collaborator

Chonnam National University Hospital

OTHER

lead

Asan Medical Center

OTHER